Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

STVN

Stevanato (STVN)

Stevanato Group SpA
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:STVN
DataHoraFonteTítuloCódigoCompanhia
31/05/202417:30Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:STVNStevanato Group SpA
30/05/202406:00Business WireStevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and CartridgesNYSE:STVNStevanato Group SpA
28/05/202417:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
28/05/202408:00Business WireStevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco MoroNYSE:STVNStevanato Group SpA
24/05/202417:10Business WireStevanato Group Announces Results of Annual General MeetingNYSE:STVNStevanato Group SpA
23/05/202417:30Business WireStevanato Group to Present at Upcoming Investor ConferencesNYSE:STVNStevanato Group SpA
20/05/202417:37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:STVNStevanato Group SpA
09/05/202407:39Business WireStevanato Group Reports Financial Results for the First Quarter of 2024NYSE:STVNStevanato Group SpA
01/05/202417:30Business WireStevanato Group to Present at the Bank of America Securities Healthcare ConferenceNYSE:STVNStevanato Group SpA
25/04/202417:04Business WireStevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024NYSE:STVNStevanato Group SpA
04/04/202409:00Business WireStevanato Group appoints Ugo Gay as Chief Operations OfficerNYSE:STVNStevanato Group SpA
26/03/202417:10Business WireStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary SharesNYSE:STVNStevanato Group SpA
22/03/202400:45Business WireStevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
20/03/202418:12Business WireStevanato Group Announces Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
11/03/202418:05Business WireStevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumNYSE:STVNStevanato Group SpA
07/03/202408:30Business WireStevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023NYSE:STVNStevanato Group SpA
22/02/202418:30Business WireStevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024NYSE:STVNStevanato Group SpA
24/01/202410:00Business WireStevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and CommercializationNYSE:STVNStevanato Group SpA
03/01/202418:30Business WireStevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:STVNStevanato Group SpA
16/11/202308:00Business WireStevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma ManufacturingNYSE:STVNStevanato Group SpA
09/11/202308:30Business WireStevanato Group to Present at the Jefferies London Healthcare ConferenceNYSE:STVNStevanato Group SpA
31/10/202307:30Business WireStevanato Group Reports Third Quarter 2023 Financial ResultsNYSE:STVNStevanato Group SpA
17/10/202317:05Business WireStevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023NYSE:STVNStevanato Group SpA
05/10/202317:05Business WireStevanato Group Announces Voting Results from its Extraordinary General MeetingNYSE:STVNStevanato Group SpA
19/09/202317:07Business WireStevanato Group to Livestream Inaugural Capital Markets Day on September 27, 2023NYSE:STVNStevanato Group SpA
28/07/202307:30Business WireStevanato Group Reports Second Quarter 2023 Financial ResultsNYSE:STVNStevanato Group SpA
14/07/202317:05Business WireStevanato Group to Report Second Quarter 2023 Financial Results on July 28, 2023NYSE:STVNStevanato Group SpA
14/06/202316:34Edgar (US Regulatory)Amended Report of Proposed Sale of Securities (144/a)NYSE:STVNStevanato Group SpA
14/06/202314:12Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:STVNStevanato Group SpA
12/06/202309:00Business WireStevanato Group Presents Vertiva™, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (up to 10mL)NYSE:STVNStevanato Group SpA
 Apresentando as notícias mais relevantes sobre:NYSE:STVN